Innovent Biologics Inc.

OTC: IVBXF · Real-Time Price · USD
12.70
0.46 (3.76%)
At close: Aug 21, 2025, 3:46 PM
12.70
0.00%
After-hours: Aug 21, 2025, 04:00 PM EDT

Innovent Biologics Ratios and Metrics

Financials in CNY. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-547.41 -52.98 -20.21 -18.07
PEG Ratio
6.00 0.97 0.62 -0.09
PS Ratio
5.50 8.78 9.67 13.28
PB Ratio
3.95 4.35 4.10 5.49
P/FCF Ratio
n/a -44.07 -13.34 -14.64
P/OCF Ratio
n/a 368.45 -22.95 -28
OCF/S Ratio
n/a 0.02 -0.42 -0.47
Debt / Equity Ratio
0.22 0.29 0.30 0.24
Quick Ratio
2.16 2.78 2.88 3.35
Current Ratio
2.35 3.00 3.29 3.79
Asset Turnover
0.44 0.30 0.26 0.26
Interest Coverage
-11.17 -17.03 -20.39 -49.83
Return on Equity
-0.01 -0.08 -0.2 -0.3
Return on Assets
n/a -0.05 -0.12 -0.19
Return on Invested Capital
-0.05 -0.09 -0.14 -0.24
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.84 0.71 0.80 0.87
Net Profit Margin
-0.01 -0.17 -0.48 -0.73
Pretax Profit Margin
-0.01 -0.18 -0.48 -0.71
Operating Profit Margin
-0.08 -0.27 -0.46 -0.73
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-0.05 -0.11 -0.38 -0.56